<DOC>
	<DOCNO>NCT01356147</DOCNO>
	<brief_summary>To evaluate effect Dornase alfa preterm late preterm neonate ventilator associate pulmonary infection . Dornase alfa effective treatment pulmonary infection patient cystic fibrosis aid mucus clearance . The bacteria cause pulmonary infection cystic fibrosis patient similar infect preterm infant . The investigator expect dornase alfa therapy improve recovery ventilator associate pulmonary infection preterm infant .</brief_summary>
	<brief_title>Dornase Alfa Therapy Ventilator Associated Lung Infections Neonatal Intensive Care Unit ( NICU )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>infant le 38 week gestation 7 day age infant ventilator associate pulmonary infection , define intubated infant moderate heavy White Blood Cells ( WBCs ) tracheal aspirate , organisms tracheal aspirate gram stain , positive endotracheal tube culture , chest xray infiltrate , consolidation atelectasis , increase oxygen ( FiO2 ) requirement clinical team decide treat systemic antibiotic therapy Extremely ill infant expect survive Critically ill infant require high frequency ventilation Infants congenital pneumonia Infants congenital malformation respiratory system ( e.g . Congenital diaphragmatic hernia , cystic adenomatoid malformation tracheoesophageal fistula ) Cyanotic congenital heart disease , chromosomal abnormality infant positive newborn screen cystic fibrosis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ventilator associate pulmonary infection</keyword>
</DOC>